Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 139, 104821
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoJournal of Clinical Microbiology, 2020
- The Role of Antibody Testing for SARS-CoV-2: Is There One?Journal of Clinical Microbiology, 2020
- Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgGJournal of Clinical Virology, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World DataJournal of Clinical Medicine, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Developing antibody tests for SARS-CoV-2The Lancet, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19Journal of Medical Virology, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020